The School of Pharmacy and Pharmaceutical Sciences has established the Edelman Endowed Chair in Experimental Therapeutics.

The endowed chair, made possible through the generous support of Linda Edelman, BS '66, will support leading scientific research dedicated to accelerating the discovery of novel therapeutic agents into effective treatments for antimicrobial resistance, which the World Health Organization cites as a significant global threat.

Brian Tsuji, professor in the Department of Pharmacy Practice; associate dean for clinical and translational sciences; and head of the Division of Clinical and Translational Therapeutics, has been named the inaugural holder of the Edelman Chair.

An expert in the treatment of infectious diseases, Tsuji is recognized internationally for his groundbreaking work on the development of innovative antibiotic therapeutics to improve the care of patients. He is principal investigator on two $3.8 million National Institutes of Health grants studying antimicrobial resistance. His laboratory has pioneered key PK/PD relationships for a number of antibiotics to guide dose selection in Phase 1, 2 and 3 clinical trials that were crucial in bringing these drugs to market and defining their clinical use.

“I am so very grateful to Linda for supporting the school and my research team’s work,” says Tsuji. “We will now be able to make critical new strides in solving bottlenecks in infectious diseases and devise novel solutions for patients who have no treatment options — this is the work that drives us.”